Search

Your search keyword '"Billeter, Adrian"' showing total 125 results

Search Constraints

Start Over You searched for: Author "Billeter, Adrian" Remove constraint Author: "Billeter, Adrian" Database Unpaywall Remove constraint Database: Unpaywall
125 results on '"Billeter, Adrian"'

Search Results

2. A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPARα and PCK1

7. Beneficial effects of intermittent fasting in NASH and subsequent HCC development are executed by concerted PPAR alpha and PCK1 action in hepatocytes

8. Endothelial Notch1 signaling in white adipose tissue promotes cancer cachexia

13. Semaphorin 3C exacerbates liver fibrosis

15. Bariatric Surgery in Patients with Obesity and End-Stage Renal Disease

18. Minimally invasivE versus open total GAstrectomy (MEGA): study protocol for a multicentre randomised controlled trial (DRKS00025765)

19. Study protocol of REpeat versus SIngle ShoT Antibiotic prophylaxis in major Abdominal Surgery (RESISTAAS I): a prospective observational study of antibiotic prophylaxis practice for patients undergoing major abdominal surgery

24. Outcome and prognostic factors in patients undergoing salvage therapy for recurrent esophagogastric cancer after multimodal treatment

28. Mechanical stretching and chemical pyloroplasty to prevent delayed gastric emptying after esophageal cancer resection—a meta-analysis and review of the literature

31. The Problem of Appetite Loss After Major Abdominal Surgery

35. Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH

36. Endoscopic Stent Placement Can Successfully Treat Gastric Leak Following Laparoscopic Sleeve Gastrectomy If and Only If an Esophagoduodenal Megastent Is Used

40. Semaphorin 3C exacerbates liver fibrosis

42. Minimally invasive partial versus total adrenalectomy for unilateral primary hyperaldosteronism-a retrospective, multicenter matched-pair analysis using the new international consensus on outcome measures

43. Author Correction: Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH

45. NASH limits anti-tumour surveillance in immunotherapy-treated HCC

46. Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH

47. Surgical immunology

49. Contributors

Catalog

Books, media, physical & digital resources